Tag: ICH
Minimally invasive surgery appears beneficial in deep and lobar intracranial haemorrhages
The MIND study—presented for the first time at this year’s International Stroke Conference (ISC; 5–7 February, Los Angeles, USA)—has revealed the potential benefits of...
Alveron Pharma closes €5 million seed extension financing to accelerate breakthrough...
Alveron Pharma has announced the closing of a €5 million series seed extension financing—worth approximately US$5.28 million—to advance the development of its innovative drug, OKL-1111,...
“Transformative” new data advocate early blood-thinning therapy in patients with atrial...
People with atrial fibrillation (AF) who have a stroke could benefit from receiving blood-thinning treatments—known as direct oral anticoagulants (DOACs)—at an earlier stage than...
Roughly half of all healthy life lost to stroke is caused...
The latest analysis of the Global Burden of Disease, Injuries and Risk Factors study (GBD), assessing data ranging from 1990–2021, has indicated that roughly...
Stryker completes acquisition of Nico Corporation
Stryker has announced that it has completed the acquisition of Nico Corporation—a company attempting to provide a systematic approach to minimally invasive surgery for...
Evidence weak but craniectomy may be superior to medical therapy in...
Despite the study very narrowly failing to meet its prespecified primary endpoint, the SWITCH randomised controlled trial has shown a substantial treatment effect with...
‘Time is brain’ in ICH but early identification of stroke type...
The latest data from the INTERACT trials—a series of studies evaluating intensive blood-pressure (BP) lowering in acute haemorrhagic stroke—point towards the importance of initiating...
Viz.ai and Nico announce collaboration to improve interventional ICH outcomes
Viz.ai has announced a collaboration with Nico Corporation to improve the lives of patients with intracranial haemorrhages (ICHs), leveraging the former’s artificial intelligence (AI)-powered...
ENRICH trial results published in full in New England Journal of...
The entirety of the results from the ENRICH trial evaluating the early surgical removal of intracranial haemorrhage (ICH) have been published in the New England...
Viz.ai gains US FDA 510(k) clearance for intracerebral haemorrhage imaging algorithm
Viz.ai has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Viz Intracerebral Haemorrhage (ICH) Plus algorithm, which is intended...
Female hormone intake and its influence on cerebral cavernous malformations
As per an observational study published in the journal Neurology last year, female hormone therapy use may be associated with a higher risk of...
Global experts call for tighter standards to speed up emergency haemorrhagic...
An international panel of clinical researchers has published a report in the journal Stroke in which they advocate “immediate change” regarding treatment protocols for...
Apotransferrin shows promise in animal models of intracranial haemorrhage
Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH)...
Latest TRIAGE-STROKE and RACECAT data put the brakes on alternative stroke...
Recently published data from two large randomised controlled trials (RCTs) have indicated there may be minimal benefits—or even negative effects—associated with bypassing local or...
AI algorithm shows promise for early intracerebral haemorrhage detection in retrospective...
Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an...
“Definitive trial” needed to confirm desmopressin’s potential in ICH patients receiving...
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the...
New ENRICH-PLUS study set to build on recent positivity in haemorrhagic...
Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000...
Latest trial results prompt call to “elevate” intracranial haemorrhage management
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...
ENRICH trial data on minimally invasive ICH surgery to be presented...
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...
Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke...
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...
Viz.ai collaborates with Johns Hopkins to expedite patient enrolment in brain...
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for...
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
NICO raises US$12.5 million in oversubscribed investment round
NICO Corporation has completed a US$12.5 million capital raise in an oversubscribed round that will scale the business, and leverage continued progress on the company's recently completed adaptive...
IRRAS announces educational webinar series alongside Jacobs Institute and University of...
IRRAS today announced the launch of a new educational webinar series, entitled “Exploring the Impact of IRRAflow's Active Fluid Exchange: Our Early Experience Utilizing...
NICO announces completed enrolment in trial evaluating new ICH intervention approach
NICO Corporation has announced that enrolment is now complete for the ENRICH (Early minimally invasive removal of ICH) randomised controlled trial, which is comparing medical and economic outcomes between early...
RapidAI receives US FDA clearance for Rapid Hyperdensity
RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...
Stroke in young people may be associated with increased likelihood of...
The risk of being diagnosed with a new cancer in the follow-up of patients with a first-ever stroke is particularly increased in patients younger...
ATTENTION results indicate “we have finally conquered the basilar artery” with...
This year’s European Stroke Organisation Conference (ESOC 2022; 4–6 May, Lyon, France) saw results from ATTENTION—a multicentre randomised controlled trial (RCT) evaluating the benefit...
